Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Lly save search
Rehabilitation Equipment Global Market to Showcase Growth at a CAGR of ~5% by 2028, Examines DelveInsight
Published: 2024-01-22 (Crawled : 23:00) - prnewswire.com
NVRO | News | $12.32 0.24% 0.0% 410K
|
Health Technology
|
| O: 2.42%
H: 0.0%
C: -3.75%
MDT | News | $79.19 0.14% 0.0% 6.1M
|
Health Technology
|
| O: 0.45%
H: 0.58%
C: -0.6%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -1.11%
H: 0.0%
C: 0.0%
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: -0.51%
H: 0.37%
C: 0.32%
BSX | $67.42 -0.8% -0.53% 5.9M
|
Health Technology
|
| O: 0.1%
H: 0.25%
C: -0.3%
ABT | News | $105.27 -0.6% -0.15% 7.3M
|
Health Technology
|
| O: -0.07%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -2.05%
H: 0.0%
C: 0.0%
DYNT | $0.59 0.86% 0.85% 780K
|
Health Technology
|
| O: -1.65%
H: 0.0%
C: -1.03%
ATEC | News | $12.345 -1.32% -1.34% 2.3M
|
Health Technology
|
| O: 1.07%
H: 0.0%
C: -0.5%
global growth market
Non-Alcoholic Fatty Liver Disease Market to Observe Impressive Growth by 2032, Evaluates DelveInsight | Key Companies - MediciNova, Eli Lilly and Company, AstraZeneca, Madrigal Pharmaceuticals, BioMarin Pharmaceutical, GlaxoSmithKline, Pfizer
Published: 2024-01-22 (Crawled : 22:00) - prnewswire.com
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: -0.51%
H: 0.37%
C: 0.32%
MDGL M | $222.18 -2.7% -2.8% 270K
|
Health Technology
|
| O: 1.29%
H: 0.35%
C: -3.04%
HEPA | $2.1 -1.41% -1.43% 28K
|
Health Technology
|
| O: -0.48%
H: 7.69%
C: 1.44%
ALT | $6.9 -1.99% -2.03% 3.2M
|
Commercial Services
|
| O: -0.8%
H: 6.02%
C: 0.6%
ALNY | $145.045 -0.19% -0.19% 400K
|
Health Technology
|
| O: 0.46%
H: 3.04%
C: 2.67%
ETNB | News | $8.9 -2.84% -2.92% 680K
|
Health Technology
|
| O: 1.19%
H: 0.63%
C: -0.72%
liver disease companies key growth market
ProQR Highlights New Platform Data from Presentation on Axiomer™ RNA Editing Technology at Deaminet 2024
Published: 2024-01-19 (Crawled : 12:00) - globenewswire.com
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: -0.15%
H: 1.16%
C: 0.99%
PRQR | $1.86 -2.11% -2.15% 180K
|
Health Technology
|
| O: 2.36%
H: 2.76%
C: -4.15%
presentation technology platform
AAV Vectors in Gene Therapy Market is Predicted to Observe Skyrocketed Growth During the Study Period (2019-2032) | DelveInsight `
Published: 2024-01-16 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -1.83%
H: 0.0%
C: 0.0%
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.77%
H: 0.17%
C: -1.65%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.45%
H: 0.06%
C: -0.5%
RGNX | News | $16.08 -5.58% -5.91% 560K
|
Health Technology
|
| O: -0.13%
H: 0.0%
C: -7.15%
ADVM | $11.135 -1.89% -1.93% 100K
|
Health Technology
|
| O: -0.69%
H: 2.32%
C: -0.12%
therapy growth study market
Sjogren's Syndrome Market to Register Sustainable Growth During the Study Period (2019-2032), Predicts DelveInsight | Key Players - Horizon Therapeutics, Dompe Farmaceutici, MorphoSys, Resolve Therapeutics, Novartis, Johnson & Johnson
Published: 2024-01-16 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -1.83%
H: 0.0%
C: 0.0%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -1.02%
H: 0.0%
C: 0.0%
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.77%
H: 0.17%
C: -1.65%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.45%
H: 0.06%
C: -0.5%
IMAB | $1.795 -0.83% -0.84% 140K
|
Health Technology
|
| O: -1.08%
H: 0.0%
C: -8.42%
resolve key growth study market
AVEO Oncology Enrolls First Patient in Pivotal FIERCE-HN Clinical Trial to Evaluate Ficlatuzumab in Combination with ERBITUX® (cetuximab) in Patients with HPV-negative Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
Published: 2024-01-16 (Crawled : 12:30) - globenewswire.com
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.15%
H: 0.59%
C: -1.45%
erbitux first cell trial
Global Erectile Dysfunction Drugs Market Research Report 2024: Novel Drug Launches Propel Growth, Growing Geriatric Population Drives Demand - Forecast to 2034
Published: 2024-01-16 (Crawled : 00:00) - prnewswire.com
MGRX | $0.291 3.19% 3.09% 270K
|
|
| O: 3.28%
H: 4.38%
C: -0.19%
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -2.03%
H: 0.05%
C: 0.05%
PTPI | $0.69 0.0% 230K
|
|
| O: 0.38%
H: 0.0%
C: -7.58%
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.15%
H: 0.59%
C: -1.45%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -1.34%
H: 0.0%
C: 0.0%
drug propel report research global growing market
Heart Failure Treatment Drug Market to Accelerate Immensely by 2032, Predicts DelveInsight
Published: 2024-01-15 (Crawled : 22:00) - prnewswire.com
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.15%
H: 0.59%
C: -1.45%
drug treatment heart market
Global Antibody Fragments Market Research Report 2023: Market to Reach $9.6 Billion by 2028 - Increasing Investments in Biopharmaceuticals Driving Growth
Published: 2024-01-15 (Crawled : 20:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -2.03%
H: 0.05%
C: 0.05%
NVS | News | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.16%
H: 0.43%
C: 0.07%
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.15%
H: 0.59%
C: -1.45%
ABBV | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: -0.49%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -1.34%
H: 0.0%
C: 0.0%
investments report antibody reach research global growth market
Gene Therapy Global Market is Projected to Grow at a CAGR of ~19% by 2028, Predicts DelveInsight
Published: 2024-01-12 (Crawled : 22:00) - prnewswire.com
TGTX | $14.0 1.3% 1.29% 3.5M
|
Health Technology
| Email alert
Add to watchlist
VRTX | $393.51 0.1% 0.1% 950K
|
Health Technology
| Email alert
Add to watchlist
RARE | $43.38 -1.65% -1.68% 770K
|
Health Technology
| Email alert
Add to watchlist
SLDB | $9.24 -7.51% -8.12% 140K
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
| Email alert
Add to watchlist
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
BLUE | $0.9583 -0.52% -0.52% 6.5M
|
Health Technology
| Email alert
Add to watchlist
NVS | News | $92.57 -0.55% 0.0% 910K
|
Health Technology
| Email alert
Add to watchlist
DTIL | $10.77 -6.43% -6.87% 71K
|
Health Technology
| Email alert
Add to watchlist
global therapy market
Gastroenteropancreatic Neuroendocrine Tumors Market to Showcase a Significant Growth by 2032, Evaluates DelveInsight | Key Players - Eli Lilly and Company, Phanes Therapeutics, Camurus AB, Advanced Accelerator Applications, PharmaMar
Published: 2024-01-11 (Crawled : 22:00) - prnewswire.com
RYZB | $62.49 0.03% 280K
|
|
| O: 0.21%
H: 0.0%
C: 0.0%
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 0.71%
H: 0.0%
C: 0.0%
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.39%
H: 0.91%
C: 0.74%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.06%
H: 0.0%
C: 0.0%
tumors key advanced growth market
Focal Segmental Glomerulosclerosis Market to Observe Impressive Growth by 2032, Predicts DelveInsight | Leading Companies - ACELYRIN, Genentech, ChemoCentryx, Travere Therapeutics, Boehringer Ingelheim, Chinook Therapeutics
Published: 2024-01-10 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 1.1%
H: 0.0%
C: 0.0%
NVO | News | $122.75 -1.43% 0.0% 2.8M
|
Health Technology
|
| O: -0.33%
H: 0.35%
C: -1.5%
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.67%
H: 0.85%
C: 0.21%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.69%
H: 0.0%
C: 0.0%
ALDX 4 | $3.99 0.5% 0.5% 430K
|
Health Technology
|
| O: -1.8%
H: 0.46%
C: -2.44%
companies therapeutics growth market
Innovent Announces the First Phase 3 Clinical Trial of Mazdutide in Chinese Adults with Overweight or Obesity Met the Primary and All Key Secondary Endpoints, and Plans to Submit NDA of Mazdutide to the NMPA
Published: 2024-01-09 (Crawled : 00:00) - prnewswire.com
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.65%
H: 0.69%
C: -0.73%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.74%
H: 0.0%
C: 0.0%
INCY | $52.82 0.19% 0.19% 1.8M
|
Health Technology
|
| O: 0.0%
H: 0.53%
C: -2.19%
obesity first chinese key trial
NanoImaging Services Appoints John Rigg as Chief Executive Officer
Published: 2024-01-08 (Crawled : 15:00) - prnewswire.com
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: 2.22%
H: 0.87%
C: -4.35%
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.63%
H: 0.58%
C: 0.58%
services
Mesa Laboratories Appoints Mark Capone to its Board of Directors
Published: 2024-01-08 (Crawled : 13:00) - globenewswire.com
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.63%
H: 0.58%
C: 0.58%
DHR | $236.36 -1.27% 0.0% 4.2M
|
Health Technology
|
| O: -0.56%
H: 2.71%
C: 2.6%
MLAB | $100.05 -1.08% -1.09% 31K
|
Health Technology
|
| O: -0.03%
H: 3.71%
C: 3.69%
Clarivate Identifies Thirteen Potential Blockbuster Drugs and Gamechangers in Annual Drugs to Watch Report
Published: 2024-01-08 (Crawled : 08:00) - prnewswire.com
ALPMF | News | $9.594 43.47% 2.2K
|
Health Technology
|
| O: -0.85%
H: 1.05%
C: 0.08%
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 2.07%
H: 0.48%
C: 0.48%
ALPMY | News | $9.46 -1.11% 500K
|
Manufacturing
|
| O: 0.53%
H: 3.97%
C: 0.45%
CLVT | News | $6.95 0.58% 0.0% 6.2M
|
Information
|
| O: 0.92%
H: 6.4%
C: 5.03%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.47%
H: 0.0%
C: 0.0%
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.63%
H: 0.58%
C: 0.58%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 1.16%
H: 0.0%
C: 0.0%
CALT | $18.3 -2.35% -2.4% 6.1K
|
Health Technology
|
| O: 2.68%
H: 3.22%
C: 0.35%
report potential
ISOMORPHIC LABS ANNOUNCES STRATEGIC MULTI-TARGET RESEARCH COLLABORATION WITH LILLY
Published: 2024-01-07 (Crawled : 20:20) - prnewswire.com
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
| Email alert
Add to watchlist
research collaboration
Lilly Launches Direct-to-Consumer Website, Services to Support Weight-Loss Drugs
Published: 2024-01-05 (Crawled : 17:00) - biospace.com/
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: -0.08%
H: 0.97%
C: 0.74%
services
Nimbus Therapeutics Announces Expansion of Its Immunology Drug Discovery Pipeline
Published: 2024-01-05 (Crawled : 14:00) - biospace.com/
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: -0.08%
H: 0.97%
C: 0.74%
drug pipeline expansion immunology therapeutics
ProQR and Rett Syndrome Research Trust Join Forces with Axiomer™ RNA Editing Collaboration
Published: 2024-01-05 (Crawled : 12:00) - globenewswire.com
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: -0.08%
H: 0.97%
C: 0.74%
PRQR | $1.86 -2.11% -2.15% 180K
|
Health Technology
|
| O: 1.5%
H: 1.48%
C: -0.25%
research collaboration trust
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.